Синдром лизиса опухоли: патогенез, клиника, профилактика, лечение

сидром лизиса опухоли, тумор-лизис-синдром, факторы риска, патогенез, клиника, лечение

1. Basile C., Montanaro A. An exceptionally severe hyperuricemia in acute renal failure caused by spontaneous tumor lysis syndrome (TLS). G Ital Nephrol 2003;20(5):525—8.

2. Yeung S.C., Lazo-Diaz G., Gagel R.F. Metabolic and endocrine emergencies. In: S.C. Yeung, C.P. Escalante (eds). Oncologic emergencies. Hamilton, BC Decker; 2002. p. 103—44.

3. Arrambide K., Toto R.D. Tumor lysis syndrome. Semin Nephrol 1993;13:273—80.

4. Flombaum C.D. Metabolic emergencies in the cancer patient. Semin Nephrol 2000;27:322—34.

5. Jones D.P., Mahmoud H., Chesney R.W. Tumor lysis syndrome. Pediatr Nephrol 1995;9:206—12.

6. Румянцев С.А., Позднякова О.О., Цубек А. и др. Сравнительный анализ причин смертности в детских онкогематологических центрах Австрии и России. Мат. конференции «Актуальные вопросы гематологии и трансфузиологии». С.-Пб.; 1996. с. 128.

7. Hsu H.H., Chan Y.L., Huanq C.C. Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: clinical features and therapeutic approach. J Nephrol 2004;17(1):50—6.

8. Семенова А.И. Гиперкальциемия и синдром распада опухоли. Практ онкол 2006;7(2):101–7.

9. Vassban E., Zaina A., Braester A., Manaster J., Horn Y. Acute tumor lysis syndrome induced by high-dose corticosteroids in a patient with chronic lymphatic leukemia. Ann Hematol 2001;80(5):314—5.

10. Duzova A., Cetin M., Gümrük F., Yetqin S. Acute tumour lysis syndrome following a singledose corticosteroid in children with acute lymphoblastic leukaemia. Eur J Hematol 2001;66(6):404—7.

11. Loosveld O.J., Schouten H.C., Gaillard C.A., Bligham G.H. Acute tumor lysis syndrome in a patient with acute lymphoblastic leukemia after a single dose of prednisone. Br J Haematol 1991;77:122—3.

12. Rostom A.Y., El-Hussainy G., Kandyl A., Allam A. Tumor lysis syndrome following hemibody irradiation for metastatic breast cancer. Ann Oncol 2000;11(10):1349—51.

13. Schiffer N., Cohen A., Lewinski U.H. Severe tumor lysis syndrome following splenic irradiation. Am J Hematol 1999;60:75—6.

14. Burney I.A. Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma. South Med J 1998;91(5):467—70.

15. Barry B.D., Kell M.R., Redmond H.P. Tumor lysis syndrome following endoscopic radiofrequency interstitial thermal ablation of colorectal liver metastases. Surg Endosc 2002;16(7):1109. Epub 2002 Apr 9.

16. Lehner S.G., Gould J.E., Saad W.E., Brown D.B. Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma. AJR Am J Roentgenol 2005;185(5):1307—9.

17. Gersosimo R.J. Monoclonal antibodies in the treatment of cancer, Part 2. Am J Health Syst 2003;60(16):1631—41; quiz 1642—3.

18. Fer M.F., Bottino G.C., Scerwin S.A. et al. Atypical tumor lysis syndrome in a patient with T cell lymphoma treated with recombinant leukocyte interferon. Am J Med 1984;77(5):953—6.

19. Castro M.P., Van Auken J., Spencer-Cisek P. et al. Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: a case report and review of the literature. Cancer 1999;85(5):1055—9.

20. Deliliers G.L., Analoro C. Hyperuricemia and bone marrow transplantation. Contrib Nephrol 2005;147:105—14.

21. Gerecitano J., Strauss D.J. Treatment of Burkitt lymphoma in adults. Expert Rev Contrib Ther 2006; 6(3):373—81.

22. Hande K.R., Garrow G.C. Acute tumor lysis syndrome in patients with high-grade nonHodgkin lymphoma. Amer J Med 1993;94:133—9.

23. Abou Mourad J., Taber A., Sbamseddine A. Acute tumor lysis syndrome in large B-cell nonHodgkin lymphoma induced by steroids and anti-CD 20. Hematol J 2003;4:222.

24. Chen S.W., Hwang W.S., Tsao C.J. et al. Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature. J Clin Pharm Ther 2005;30(6):623—5.

25. Bubala H., Sonts-Jakimczyk D., Szczenanska M. Tumor lysis syndrome in the course of acute lymphoblastic leukemia as the consequence of prednisone monotherapy. Pol Mercur Lekarski 2003;15(86):182—4.

26. Hummel M., Buchheidt D., Reiter S. et al. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia — successful treatment and prevention of TLS with low-dose rasburicase. Eur J Haematol 2005;75(6):518—21.

27. Woo I.S., Kim J.S., Part M.J. et al. Spontaneous acute tumor lysis syndrome with advanced gastric cancer. J Korean Med Sci 2001;16:115—8.

28. Kalemkerian G.P., Darwish B., Varterasian M.L. Tumor lysis syndrome in small cell carcinoma and other solid tumors. Am J Med 1997;103:363—7.

29. Persons D.A., Garst J., Vollmer R., Crawford J. Tumor lysis syndrome and acute renal failure after treatment of non-small-cell lung carcinoma with combination irinotecan and cisplatin. Am J Clin Oncol 1998;21:426—9.

30. Drakos P., Bar-Ziv J., Catane R. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature. Am J Clin Oncol 1994;17:502—5.

31. Bilgrami S.F., Fallon B.G. Tumor lysis syndrome after combination chemotherapy for ovarian cancer. Med Pediatr Oncol 1993;21:521—4.

32. Baeksqaard L., Sorensen J.B. Acute tumor lysis syndrome in solid tumors — a case report and review of the literature. Cancer Chemother Pharmacol 2003;51(3):187—92.

33. Locatelli F., Rossi F. Incidence and pathogenesis of tumor lysis syndrome. Contrib Nephrol 2005;147:61—8.

34. Hussain K., Massa J.J., Clouse L.H. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature. Am J Hematol 2003;72(3):212—5.

35. Yeung S.C., Escalante C. Cancer medicine. In: S.C. Yeung, C.P. Escalante (eds). Oncologic emergencies. Hamilton, BC Decker; 2003. p.2662—3.

36. Mato A.R., Riccio B.E., Oin L. et al. A predictive model for the detection of tumor lysis syndrome during AML induction therapy. Leuk Lymphoma 2006;47(5):877—83.

37. Kopecna L., Dolezel Z., Osvaldova Z. et al. The analysis of the risks for the development of tumor lysis syndrome in children. Bratisl Lek Listy 2002;103(6):206—9.

38. Van Der Klooster J.M., Van Der Wiel H.E., Van Saase J.L., Grootendorst A.F. Asystole during combination chemotherapy for nonHodgkin lymphoma: the acute tumor lysis syndrome. Neth J Med 2000;56:147—52.

39. Vachvanichsanong P., Maipang M., Dissaneewate P. et al. Severe hyperphosphatemia following acute tumor lysis syndrome. Med Pediatr Oncol 1995;24(1):63—6.

40. Boles J.M., Dutel J.L., Briere J. Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia. Cancer 1984;53(11):2425—9.

41. Macher M.A., Loirat C., Pillion G., Maisin A. Acute kidney failure caused by hyperphosphoremia in tumor lysis. Arch Fr Pediatr 1988;45(4):271—4.

42. Sacarcan A., Quigley R. Hyperphosphatemia in tumor lysis syndrome: the role of hemodialysis and continuous venovenous hemofiltration. Pediatr Nephrol 1994;8(3):351—3.

43. Jeha S. Tumor lysis syndrome. Semin Hematol 2001;38(4 Suppl 10):4—8.

44. Ворожейкина Е.Г., Бирюкова Л.С., Савченко В.Г. Синдром массивного цитолиза опухоли. Тер арх 2006;78(7):99–103.

45. Hande K.R., Garrow G.C. Acute tumor lysis syndrome in patients with high-grade nonHodgkin's lumphoma. Am J Med 1993;94(2):133—9. Review.

46. Cairo M.S., Bishop M. Tumor lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004;127:3—11.

47. Feusner J., Farber M.S. Role of intravenous allopurinol in the management of acute tumor lysis syndrome. Semin Oncol 2001;28:13.

48. Seftel M.D., Bruiere H., Copland M. et al. Fulminant tumor lysis syndrome in acute mielogenous leukemia with inv(16)(p13;q22). Eur J Hematol 2002;69:193—9.

49. Smally R.V., Guaspari A. et al. Allopurinol: intravenous use for prevention and treatment of hyperuricemia. J Clin Oncol 2000;18:1758—63.

50. Patte C., Sakiroglu C., Ansoborlo S. et al. Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Societe Francaise d'Oncologie Pediatrique LMB89 protocol. Ann Oncol 2002;13(5):789—95.

51. Wang L.Y., Shin L.Y., Chang H. Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies. Acta Hematol 2006;115(1—2):35—8.

52. Schelling J.R., Ghandour F.Z., Strickland T.J., Sedor J.R. Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature. Ren Fail 1998;20(4):635—44.

53. Rampello E., Fricia T., Malaquarnera M. The management of tumor lysis syndrome. Nat Clin Pract Oncol 2006;3(8):438—47.

54. Saccente S.L., Kohaut E.C., Berkow R.L. Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration. Pediatr Nephrol 1995;9(5):569—73.

55. Aqha-Razii M., Amyott S.L., Pichette V. et al. Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia. Clin Nephrol 2000;54(1):59—63.